Description
Tissue & Recovery Research Peptides
Lyophilised Powder
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a partial sequence of a protective protein isolated from gastric juice. BPC-157 has been the subject of extensive published research since the 1990s, with over 100 peer-reviewed studies examining its biological activity in various experimental models.
Published literature has investigated BPC-157’s effects on angiogenesis, nitric oxide system modulation, and growth factor expression in cell culture and animal models. Research has examined its interactions with multiple biological pathways, including the FAK-paxillin signalling cascade, vascular endothelial growth factor (VEGF) expression, and the nitric oxide (NO) system. Studies have explored its activity in tendon, ligament, muscle, bone, and gastrointestinal tissue models. The peptide’s cytoprotective properties and interaction with the dopaminergic and serotonergic systems have also been described in published experimental research.
This product is supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. It is intended exclusively for use in controlled laboratory settings by qualified researchers.
Product Specifications
| Compound | BPC-157 (Body Protection Compound-157) |
| Quantity | 10mg per vial |
| Form | Lyophilised powder |
| Purity | 98%+ (verified by third-party HPLC analysis) |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Molecular Weight | ~1,419.53 Da |
| CAS Number | 137525-51-0 |
| Appearance | White powder |
Certificate of Analysis
View CoA — Janoshik Analytical
Independent third-party testing by Janoshik Analytical (Czech Republic). Tests include HPLC purity analysis and mass spectrometry identification.
Storage Instructions
After reconstitution: Store at 2–8°C. Use within 14 days for optimal stability. Do not freeze once reconstituted.



